Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The Czech Republic has high acceptance of cannabis, and a long-standing tradition of cannabis cultivation and usage. Cannabis legislation has been an issue in the country since the 1990s, when there was an early attempt to legalise cannabis. Currently medical cannabis is legal, and is growing thanks to active interest on the part of government and patients. CBD products are also legal and growing, widely available in online retailers, pharmacies and drugstores. Recreational cannabis is illegal.
Euromonitor International's Cannabis in Czech Republic market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market - legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2024 illustrate how the market is set to expand and change.
Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.